Characterization of ferroptosis signature to evaluate the predict prognosis and immunotherapy in glioblastoma

Background: Glioblastoma (GBM) is the most common type of brain cancer with poor survival outcomes and unsatisfactory response to current therapeutic strategies. Recent studies have demonstrated that ferroptosis-related genes (FRGs) are linked with the occurrence and development of GBM and may become promising biological indicators in GBM therapy. Methods: We systematically assessed the relationship between FRGs expression profiles and prognosis...